On August 19, Astellas Pharma and FibroGen announced that the European Commission (EC) has approved the listing of EVREN
Cotignola, Italy, September 3, 2020 - Concept Medical Inc., which focuses on vascular interventional drug delivery devic
From January 23 to January 31, officially go to work on February 1.
A study by the Paul Scherrer Institute in Switzerland, in collaboration with Roche, a well-known multinational pharmaceu
141 genes may help explain the genetic risk of asthma, hay fever and eczema Recently,a research report published in the
Three major trends in the development of antihypertensive drugs Poor compliance is one of the main problems to be solve